Selected article for: "double placebo and placebo group"

Author: Leaker, Brian R.; Singh, Dave; Lindgren, Sam; Almqvist, Gun; Eriksson, Leif; Young, Barbara; O’Connor, Brian
Title: Effects of the Toll-like receptor 7 (TLR7) agonist, AZD8848, on allergen-induced responses in patients with mild asthma: a double-blind, randomised, parallel-group study
  • Document date: 2019_12_19
  • ID: 15e043uf_12
    Snippet: This was a double-blind, placebo-controlled, randomised, parallel-group study in patients with mild-to-moderate allergic asthma, conducted at two centres in the UK ( Fig. 1 and Additional file 1: Figure S1 ). The study comprised an initial screening period of up to 8 weeks prior to randomisation, during which a methacholine challenge and an allergen challenge titration were performed......
    Document: This was a double-blind, placebo-controlled, randomised, parallel-group study in patients with mild-to-moderate allergic asthma, conducted at two centres in the UK ( Fig. 1 and Additional file 1: Figure S1 ). The study comprised an initial screening period of up to 8 weeks prior to randomisation, during which a methacholine challenge and an allergen challenge titration were performed.

    Search related documents:
    Co phrase search for related documents
    • additional file and parallel group: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71
    • additional file and parallel group study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • additional file and placebo control: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
    • additional file and screening period: 1, 2
    • allergen challenge titration and challenge titration: 1
    • allergen challenge titration and screening period: 1
    • allergic asthma and methacholine challenge: 1
    • allergic asthma and moderate mild allergic asthma: 1, 2
    • allergic asthma and parallel group: 1
    • allergic asthma and parallel group study: 1
    • allergic asthma and placebo control: 1
    • challenge titration and screening period: 1
    • initial screening period and screening period: 1, 2, 3, 4, 5
    • methacholine challenge and moderate mild allergic asthma: 1
    • methacholine challenge and parallel group: 1
    • methacholine challenge and parallel group study: 1
    • moderate mild allergic asthma and parallel group: 1
    • moderate mild allergic asthma and parallel group study: 1
    • moderate mild allergic asthma and placebo control: 1